Comment on "Dysregulated production of leukemia inhibitory factor in immune cells of relapsing remitting multiple sclerosis patients" by Levy et al. J. Neuroimmunol. 2015 Jan 15; 278C:85-89

Joris Vanderlocht, Niels Hellings*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)56-57
JournalJournal of Neuroimmunology
Publication statusPublished - 15 Mar 2015

Cite this